Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome

Mutation Research - Reviews in Mutation Research

Volumn 727, Issue 3, 2011, Pages 55-61

  Herceg, Zdenko ^a   Paliwal, Anupam ^a,b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Cancer risk factor; DNA methylation; Environment; Epigenetics; Histone modifications; Liver cancer; Noncoding RNAs

Indexed keywords

AFLATOXIN; MICRORNA; UNTRANSLATED RNA;

ALCOHOL CONSUMPTION; CANCER GROWTH; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION PROFILING; GENE SILENCING; GENOME; HEPATITIS B; HEPATITIS C; HISTONE MODIFICATION; HUMAN; LIFESTYLE; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW;

CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; HISTONES; HUMANS; LIVER NEOPLASMS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 79957485296     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2011.04.001     Document Type: Review

References (57)

1. Block T.M., Mehta A.S., Fimmel C.J., Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107.
2. Herath N.I., Leggett B.A., MacDonald G.A. Review of genetic and epigenetic alterations in hepatocarcinogenesis. J. Gastroenterol. Hepatol. 2006, 21:15-21.
3. Li H.P., Leu Y.W., Chang Y.S. Epigenetic changes in virus-associated human cancers. Cell Res. 2005, 15:262-271.
4. Fernandez A.F., Esteller M. Viral epigenomes in human tumorigenesis. Oncogene 2010, 29:1405-1420.
5. Paterlini-Brechot P., Saigo K., Murakami Y., Chami M., Gozuacik D., Mugnier C., Lagorce D., Brechot C. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 2003, 22:3911-3916.
6. Calvisi D.F., Ladu S., Gorden A., Farina M., Lee J.S., Conner E.A., Schroeder I., Factor V.M., Thorgeirsson S.S. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 2007, 117:2713-2722.
7. Baylin S.B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2005, 2(Suppl. 1):S4-S11.
8. Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007, 22:91-103.
9. Sawan C., Vaissiere T., Murr R., Herceg Z. Epigenetic drivers and genetic passengers on the road to cancer. Mutat. Res. 2008, 642:1-13.
10. Vaissiere T., Sawan C., Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 2008, 659:40-48.
11. Baylin S.B., Chen W.Y. Aberrant gene silencing in tumor progression: implications for control of cancer. Cold Spring Harb. Symp. Quant. Biol. 2005, 70:427-433.
12. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
13. Lambert M.P., Paliwal A., Vaissiere T., Chemin I., Zoulim F., Tommasino M., Hainaut P., Sylla B., Scoazec J.Y., Tost J., Herceg Z. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J. Hepatol. 2011, 54:705-715.
14. Edamoto Y., Hara A., Biernat W., Terracciano L., Cathomas G., Riehle H.M., Matsuda M., Fujii H., Scoazec J.Y., Ohgaki H. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int. J. Cancer 2003, 106:334-341.
15. Huang J., Wang Y., Guo Y., Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010, 52:60-70.
16. Park S.H., Jung J.K., Lim J.S., Tiwari I., Jang K.L. HBV X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation. J. Gen. Virol. 2011.
17. Um T.H., Kim H., Oh B.K., Kim M.S., Kim K.S., Jung G., Park Y.N. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J. Hepatol. 2010.
18. Hernandez-Vargas H., Lambert M.P., Le Calvez-Kelm F., Gouysse G., McKay-Chopin S., Tavtigian S.V., Scoazec J.Y., Herceg Z. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One 2010, 5:e9749.
19. Herceg Z., Paliwal A. HBV protein as a double-barrel shot-gun targets epigenetic landscape in liver cancer. J. Hepatol. 2009, 50:252-255.
20. H. Hernandez-Vargas, M.P. Lambert, F. Le Calvez-Kelm, G. Gouysse, S. McKay-Chopin, S.V. Tavtigian, J.Y. Scoazec, Z. Herceg, Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors, PLoS One 5 e9749.
21. Duong F.H., Christen V., Lin S., Heim M.H. Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology 2010, 51:741-751.
22. Higgs M.R., Lerat H., Pawlotsky J.M. Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res. 2010, 70:4901-4911.
23. Horikawa I., Barrett J.C. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003, 24:1167-1176.
24. Park I.Y., Sohn B.H., Yu E., Suh D.J., Chung Y.H., Lee J.H., Surzycki S.J., Lee Y.I. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007, 132:1476-1494.
25. Shon J.K., Shon B.H., Park I.Y., Lee S.U., Fa L., Chang K.Y., Shin J.H., Lee Y.I. Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res. 2009, 139:14-21.
26. Zheng D.L., Zhang L., Cheng N., Xu X., Deng Q., Teng X.M., Wang K.S., Zhang X., Huang J., Han Z.G. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J. Hepatol. 2009, 50:377-387.
27. Gao P., Wong C.C., Tung E.K., Lee J.M., Wong C.M., Ng I.O. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J. Hepatol. 2010.
28. Li L.M., Hu Z.B., Zhou Z.X., Chen X., Liu F.Y., Zhang J.F., Shen H.B., Zhang C.Y., Zen K. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 2010, 70:9798-9807.
29. Yang L., Ma Z., Wang D., Zhao W., Chen L., Wang G. MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol. Ther. 2010, 9:803-808.
30. Zhang X., Liu S., Hu T., He Y., Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50:490-499.
31. Duong F.H., Filipowicz M., Tripodi M., La Monica N., Heim M.H. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004, 126:263-277.
32. Huang J. Current progress in epigenetic research for hepatocarcinomagenesis. Sci. China C Life Sci. 2009, 52:31-42.
33. Miura K., Taura K., Kodama Y., Schnabl B., Brenner D.A. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008, 48:1420-1429.
34. Henke J.I., Goergen D., Zheng J., Song Y., Schuttler C.G., Fehr C., Junemann C., Niepmann M. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 2008, 27:3300-3310.
35. Hou W., Tian Q., Zheng J., Bonkovsky H.L. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 2010, 51:1494-1504.
36. Pal-Bhadra M., Bhadra U., Jackson D.E., Mamatha L., Park P.H., Shukla S.D. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. Life Sci. 2007, 81:979-987.
37. Yang H., Nie Y., Li Y., Wan Y.J. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells. Exp. Biol. Med. (Maywood) 2010, 235:32-39.
38. Zhang Y.J., Rossner P., Chen Y., Agrawal M., Wang Q., Wang L., Ahsan H., Yu M.W., Lee P.H., Santella R.M. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients,. Int. J. Cancer 2006, 119:985-991.
39. Zhao W., Liu H., Liu W., Wu Y., Chen W., Jiang B., Zhou Y., Xue R., Luo C., Wang L., Jiang J.D., Liu J. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Int. J. Oncol. 2006, 28:1081-1088.
40. Zeng C., Wang R., Li D., Lin X.J., Wei Q.K., Yuan Y., Wang Q., Chen W., Zhuang S.M. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 2010, 52:1702-1712.
41. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 2003, 4:351-358.
42. Tischoff I., Tannapfe A. DNA methylation in hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:1741-1748.
43. Kanai Y., Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 2007, 28:2434-2442.
44. Kaur P., Paliwal A., Durantel D., Hainaut P., Scoazec J.Y., Zoulim F., Chemin I., Herceg Z. DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection. J. Infect. Dis. 2010, 202:700-704.
45. van Attikum H., Gasser S.M. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 2009, 19:207-217.
46. Magerl C., Ellinger J., Braunschweig T., Kremmer E., Koch L.K., Holler T., Buttner R., Luscher B., Gutgemann I. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Hum. Pathol. 2010, 41:181-189.
47. Cougot D., Wu Y., Cairo S., Caramel J., Renard C.A., Levy L., Buendia M.A., Neuveut C. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem. 2007, 282:4277-4287.
48. Pollicino T., Raffa G., Costantino L., Lisa A., Campello C., Squadrito G., Levrero M., Raimondo G. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007, 45:277-285.
49. Latham J.A., Dent S.Y. Cross-regulation of histone modifications. Nat. Struct. Mol. Biol. 2007, 14:1017-1024.
50. Gramantieri L., Fornari F., Callegari E., Sabbioni S., Lanza G., Croce C.M., Bolondi L., Negrini M. MicroRNA involvement in hepatocellular carcinoma. J. Cell. Mol. Med. 2008, 12:2189-2204.
51. Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis. 2010, 42(Suppl. 3):S206-S214.
52. Fernandez A.F., Rosales C., Lopez-Nieva P., Grana O., Ballestar E., Ropero S., Espada J., Melo S.A., Lujambio A., Fraga M.F., Pino I., Javierre B., Carmona F.J., Acquadro F., Steenbergen R.D., Snijders P.J., Meijer C.J., Pineau P., Dejean A., Lloveras B., Capella G., Quer J., Buti M., Esteban J.I., Allende H., Rodriguez-Frias F., Castellsague X., Minarovits J., Ponce J., Capello D., Gaidano G., Cigudosa J.C., Gomez-Lopez G., Pisano D.G., Valencia A., Piris M.A., Bosch F.X., Cahir-McFarland E., Kieff E., Esteller M. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 2009, 19:438-451.
53. Feitelson M.A. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett. 2006, 239:10-20.
54. Lupberger J., Hildt E. Hepatitis B virus-induced oncogenesis. World J. Gastroenterol. 2007, 13:74-81.
55. Tang H., Oishi N., Kaneko S., Murakami S. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci. 2006, 97:977-983.
56. Guo Y., Li Y., Mu S., Zhang J., Yan Z. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J. Med. Virol. 2009, 81:1177-1183.
57. Jung J.K., Arora P., Pagano J.S., Jang K.L. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007, 67:5771-5778.